Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 4/20 | 0.57 |
| ▸ | MAOB | P27338 | 6/20 | 0.52 |
| ▸ | SLC2A1 | P11166 | 2/20 | 0.52 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.51 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18127104 | 0.91 | CASR (0.53) | ADRB1ADRB3MEN1KMT2A | |
| SCHEMBL23802883 | 0.83 | ADRB1 (0.53) | ADRB1ADRB3MEN1KMT2A | |
| SCHEMBL10877683 | 0.83 | ADRB1 (0.53) | ADRB1ADRB3MEN1KMT2A | |
| SCHEMBL23802882 | 0.83 | ADRB1 (0.53) | ADRB1ADRB3MEN1KMT2A | |
| SCHEMBL10878607 | 0.83 | ADRB1 (0.53) | ADRB1ADRB3MEN1KMT2A | |
| SCHEMBL18127109 | 0.81 | CASR (0.49) | BCHEMAOBMEN1KMT2A | |
| SCHEMBL18114414 | 0.78 | L3MBTL1 (0.52) | BCHEMEN1KMT2A | |
| SCHEMBL18114454 | 0.78 | SMN1; SMN2 (0.47) | MEN1KMT2A | |
| SCHEMBL5271341 | 0.78 | BCHE (0.64) | BCHEMAOBSLC2A1MEN1KMT2A | |
| SCHEMBL17923855 | 0.78 | LTA4H (0.52) | BCHEMAOBSLC2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016160677-A1 | COMPOUNDS FOR THE TREATMENT OF ARENAVIRUS INFECTION | ARISAN THERAPEUTICS INC. (US) | 2016-10-06 | — | — | WO | disclosed |